Presentation TCT 2012

TWENTE 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents

Presenter: Clemens von Birgelen

October 25, 2012

REGISTER for free or LOG IN to view this content

TWENTE 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents

DES/BRS/DCB

Presentation

TCT 2012

Up Next

Presentation TCT 2012

Defending the TVT Registry as a Mechanism to Facilitate Expansion of TAVR Clinical Indications

Presenter: E. Murat Tuzcu

October 25, 2012

More slides +

Presentation TCT 2012

Outcomes of ASD Closure with a Deficient Rim

Presenter: Frank Ing

October 25, 2012

Presentation TCT 2012

Has Progress Been Made with Post-MI VSD Closure?

Presenter: Eustaquio Maria Onorato

October 25, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.